# Only the Right Tests Can Stop This Ebola Outbreak. Congo Has Hardly Any
The Democratic Republic of Congo faces a critical diagnostic gap as Ebola spreads with minimal testing capacity to confirm cases. A chronic shortage of investment in diagnostic development has left healthcare workers unable to quickly identify infected patients, allowing the virus to circulate unchecked through communities.
Rapid, accurate testing forms the backbone of outbreak control. When clinicians cannot confirm Ebola cases quickly, patients remain undiagnosed in hospital wards or community settings, transmitting the virus to healthcare workers, family members, and others. Delays in confirmation also prevent public health teams from isolating contacts and containing spread.
Congo's healthcare system lacks sufficient diagnostic resources despite repeated Ebola outbreaks since 1976. The country has experienced multiple epidemics, yet development of affordable, deployable testing technology has never received adequate funding from global health institutions or pharmaceutical companies. This reflects a broader pattern where diagnostic tools remain underfunded compared to treatment development or vaccine research.
Real-time PCR tests, which detect viral genetic material, represent the gold standard for Ebola confirmation but require specialized equipment and trained technicians. These tests remain concentrated in capital cities, leaving rural areas where transmission often begins without diagnostic capacity. Rapid antigen tests exist but perform inconsistently and require confirmation through PCR anyway.
The testing deficit creates cascading failures. Suspected cases go unconfirmed, healthcare workers lack clarity on infection risk, and contact tracing becomes impossible without confirmed cases to trace from. Each day without diagnosis increases transmission probability.
Addressing this requires sustained investment in diagnostic infrastructure, training laboratory personnel, and developing tests suitable for resource-limited settings. Global health funding priorities must shift to recognize that outbreak prevention depends on rapid diagnosis as much as treatment or prevention. Without investment in diagnostic capacity now, Congo and other vulnerable regions will remain blind to viral threats,